Trade this ETF at your broker
Index | Dow Jones Switzerland Titans 30 |
Investment focus | Equity, Switzerland |
Fund size | EUR 136 m |
Total expense ratio | 0.25% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | CHF |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 11.54% |
Inception/ Listing Date | 1 December 2008 |
Distribution policy | Distributing |
Distribution frequency | Annually |
Fund domicile | Luxembourg |
Fund Provider | Amundi ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | CACEIS BANK Luxembourg S.A. |
Investment Advisor | |
Custodian Bank | CACEIS Bank Luxembourg S.A. |
Revision Company | PWC |
Fiscal Year End | 30 September |
Swiss representative | CACEIS (Switzerland) SA |
Swiss paying agent | CACEIS Bank, Paris, succursale de Nyon / Suisse |
Tax data | Bundesanzeiger | |
Germany | Unknown | |
Switzerland | No ESTV Reporting | |
Austria | Non-Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Novartis AG | 10.06% |
Roche Holding AG | 9.49% |
Nestlé SA | 9.37% |
UBS Group AG | 7.56% |
ABB Ltd. | 7.06% |
Zurich Insurance Group AG | 6.88% |
Compagnie Financière Richemont SA | 5.63% |
Holcim Ltd. | 4.01% |
Sika AG | 3.97% |
Alcon AG | 3.81% |
Switzerland | 97.26% |
Other | 2.74% |
Health Care | 29.96% |
Financials | 23.50% |
Industrials | 12.62% |
Consumer Staples | 11.37% |
Other | 22.55% |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
0.00€ | 0.00€ | View offer* | ||
0.00€ | 0.00€ | View offer* | ||
0.00€ | 0.00€ | View offer* | ||
0.00€ | 0.00€ | View offer* | ||
0.00€ | 0.00€ | View offer* |
Broker | Rating | Order fee | ETF savings plans | |
---|---|---|---|---|
0.00€ | 2593 | View offer* | ||
1.00€ | 2414 | View offer* | ||
0.00€ | 1624 | View offer* | ||
0.00€ | 1087 | View offer* | ||
0.00€ | 897 | View offer* |
YTD | +8.17% |
1 month | -4.21% |
3 months | -1.65% |
6 months | +3.55% |
1 year | +17.71% |
3 years | +12.53% |
5 years | +54.92% |
Since inception (MAX) | +403.10% |
2023 | +17.20% |
2022 | -13.69% |
2021 | +30.97% |
2020 | +4.52% |
Current dividend yield | - |
Dividends (last 12 months) | - |
Period | Dividend in EUR | Dividend yield in % |
---|---|---|
1 Year | - | - |
2023 | EUR 3.99 | 3.04% |
2022 | EUR 2.92 | 1.88% |
2021 | EUR 2.66 | 2.20% |
2020 | EUR 2.48 | 2.09% |
Volatility 1 year | 11.54% |
Volatility 3 years | 14.09% |
Volatility 5 years | 16.39% |
Return per risk 1 year | 1.53 |
Return per risk 3 years | 0.28 |
Return per risk 5 years | 0.56 |
Maximum drawdown 1 year | -5.59% |
Maximum drawdown 3 years | -19.06% |
Maximum drawdown 5 years | -30.04% |
Maximum drawdown since inception | -30.04% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
XETRA | EUR | C030 | C030 GY C030EUIV | C030.DE C030EURINAV=SOLA | BNP Paribas Arbitrage |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
Xtrackers Swiss Large Cap UCITS ETF 1D | 1,214 | 0.30% p.a. | Distributing | Full replication |
Xtrackers Swiss Large Cap UCITS ETF 1C | 495 | 0.30% p.a. | Accumulating | Full replication |
iShares SLI UCITS ETF (DE) | 404 | 0.51% p.a. | Distributing | Full replication |
Xtrackers SLI UCITS ETF 1D | 307 | 0.25% p.a. | Distributing | Full replication |
Amundi MSCI Switzerland UCITS ETF CHF | 204 | 0.25% p.a. | Accumulating | Swap-based |